Microsoft (MSFT) received a Sector Outperform rating by Scotiabank due in part to its position in the artificial intelligence ...

Canadian Natural Resources upgraded at Scotiabank after lagging Canadian and international large-cap peers due to tariff ...

Scotiabank reduced their FY2025 earnings estimates for shares of Freeport-McMoRan in a note issued to investors on Wednesday, ...

The Spurs are currently 10-22 on the road with a point differential of -2, while the Raptors have a 4-6 record in their last ...

As hostility towards climate action ramps up in the U.S., sustainability-focused investors are pressing the banks to more ...

Investment analysts at Scotiabank lifted their FY2025 earnings per share estimates for Cameco in a research report issued on ...

Earn a secure dividend income of over $150 every quarter by investing in these reliable Canadian dividend stocks.

In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price ...

Scotiabank raised the firm’s price target on Alnylam (ALNY) to $338 from $300 and keeps an Outperform rating on the shares. The firm expects Amvuttra, the first transthyretin silencer to enter the ...

Fintel reports that on March 20, 2025, Scotiabank initiated coverage of Microsoft (NasdaqGS:MSFT) with a Sector Outperform ...

“It’s the opposite of last year,” said Roughnecks head coach Josh Sanderson. “We’re playing a bit more focused game on the ...

Season tickets in some of the gold sections in the lower bowl, meanwhile, are being raised more than $2,000 to $28,240 for a ...